ceftriaxone
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pneumonia
Conditions
Pneumonia
Trial Timeline
Oct 1, 2000 → Oct 1, 2003
NCT ID
NCT00374959About ceftriaxone
ceftriaxone is a approved stage product being developed by Roche for Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT00374959. Target conditions include Pneumonia.
What happened to similar drugs?
4 of 20 similar drugs in Pneumonia were approved
Approved (4) Terminated (3) Active (14)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00374959 | Approved | Completed |
Competing Products
20 competing products in Pneumonia